Table 3.
HSIL at final visit |
P-value |
|||||
---|---|---|---|---|---|---|
Baseline cytology smear results | Dapivirine vaginal ring (n = 7) | Placebo vaginal ring (n = 6) | Oral placebo (n = 12) | Dapivirine versus placebo vaginal ring | Dapivirine vaginal ring versus oral placebo | Placebo vaginal ring versus oral placebo |
Negative for intraepithelial lesion | 4 (57%) | 4 (67%) | 5 (42%) | 0.89 | 0.67 | 0.41 |
ASC-US | 1 (14%) | 1 (17%) | 1 (8%) | |||
LSIL | 2 (29%) | 1 (17%) | 6 (50%) |
P-value for comparison of baseline cytology smear results for ASPIRE dapivirine vaginal ring arm, placebo vaginal ring arm and VOICE oral placebo arm participants with a final visit HSIL result is from Cochran–Mantel–Haenszel tests for general association. ASC-US, atypical squamous cells of undetermined significance; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion.